Earth Science Tech, Inc. filings document formal public-company disclosures for a Florida issuer with common stock quoted over the counter. The record includes Form 8-K reports covering Regulation FD releases, financial-result announcements, the launch of MyOnlineConsultation.com through MOCTeledoc, and the company’s SIC 2834 pharmaceutical classification.
Other filings disclose governance and capital-structure matters, including bylaw amendments for electronic shareholder notices, officer and director compensation arrangements, auditor changes, investor-relations engagement, and the registered class of ETST common stock. These documents tie the company’s healthcare portfolio disclosures to its reporting controls, board practices and OTC security status.
Earth Science Tech, Inc. (ETST) filed an 8-K announcing it issued a press release sharing results for the period ended September 30, 2025. The disclosure is furnished under Item 7.01 (Regulation FD) and is not deemed “filed” for purposes of Section 18, nor incorporated by reference unless expressly stated. Exhibit 99.1 contains the press release, and Exhibit 104 provides the cover page Inline XBRL data. The report was signed by Giorgio R. Saumat, CEO and Chairman.
Earth Science Tech, Inc. (ETST) filed its Q2 FY2026 10‑Q, reporting higher sales and profits. For the quarter ended September 30, 2025, revenue was $9,050,626 with gross profit of $6,723,984 (74% margin). Net income was $945,897, or $0.003 per share. For the six months, revenue reached $17,810,816, gross profit $12,814,758 (71% margin), and net income $1,402,611 ($0.005 per share).
The balance sheet showed total assets of $8,667,416 and stockholders’ equity of $5,075,823. Cash was $1,235,374. Operating cash flow was $1,181,196, offset by investing cash outflows of $940,788 and financing cash outflows of $478,262.
The company continued its buyback program, repurchasing 1,510,000 shares in the quarter for $282,370, and 2,560,296 shares year‑to‑date for $469,428. Subsequent to quarter‑end, 744,603 additional shares were repurchased. ETST completed acquisitions on April 1, 2025 (Las Villas Health and DOConsultations for $200,000; 80% of Magnefuse for $240,500), and recorded related goodwill. As of October 29, 2025, common shares outstanding were 292,407,607 and preferred shares were 1,000,000.
Earth Science Tech (ETST) amended its Articles of Incorporation to reduce its authorized common stock, lowering the limit from 350,000,000 to 300,000,000 shares. The change was approved by majority shareholder written consent and a corporate resolution on August 19, 2025, and the State of Florida stamped and uploaded the amendment on October 10, 2025.